Jul 31, 2020

The National Hemophilia Foundation is thrilled to highlight several exciting, certified educational offerings for physicians, nurses and social workers at the upcoming 72nd Bleeding Disorders Conference (BDC). The following sessions, plus the entire BDC program, will be readily accessible on our virtual platform.

The medical, nursing, and social work tracks are certified for AMA PRA Category 1 Credits™, ACPE contact hours, ANCC contact hours, and Social Work CE credit.

Physicians mark your calendars for “The Next Wave: Clinical Updates on New and Emerging Treatment Options in Hemophilia,” a two-part, medical session taking place on August 6th  and 7th. In the first part, Dr. Mark Reding and Dr. Robert Sidonio Jr. will be discussing next generation factor concentrates such as BIVV001 and providing the latest clinical study data on emicizumab. In part two, Dr. Margaret Ragni and Dr. Guy Young will be providing the latest clinical updates on several novel non-factor replacement therapies in development, such as fitusiran and TFPI inhibitors.  

Part I   Thursday, August 6th, 5:30pm-7pm EST
Part II  Friday, August 7th, 5:30pm-7pm EST

Nurses join us as we hit the ground running with “Management of Patients on Novel Therapies.” This session, which kicks off your education track, will feature an update from NHF’s latest Nursing Excellence fellowship recipient Lydia Johnson, an extensive clinical overview of current novel therapies by Dr. Robert Sidonio, Jr, and conclude with a truly multidisciplinary healthcare provider panel discussing complex patient cases. This session will be Saturday, August 1st, 2pm-5pm EST

And stay tuned the next day, Sunday, August 2nd, for an excellent double feature:

“Walking A New Pathway: Coagulation & Measures of Hemostasis”
3pm-4pm EST

Jim Munn, MS, BS BSN, RN-BC and Kerry Hansen, RN will review the cell-based theory of hemostasis and how it relates to the “coagulation cascade,” specific laboratory assays, and how these assays help guide individualized treatment options in hemophilia.

“Disorders of Fibrinogen”
4pm-5pm EST

Kimberly Hurdstrom, RN, BSN and Dr. Marilyn Manco-Johnson, MD, will look at fibrinogen disorders: their prevalence, range of presentations, types of treatment, and outcomes. They will discuss treatment of acute bleeding, acute clotting, surgery, pregnancy and delivery, genetic testing, as well as prophylaxis. The session will also feature a discussion of relevant case presentations.

Social workers be sure not to miss two sessions that will spotlight two very important and timely topics that will speak to you and your colleagues who are working the front lines during the COVID-19 pandemic.  

“COVID-19 and Provider Mental Health”
Monday, August 3rd 6pm-7pm

During the COVID-19 pandemic, social workers have been “essential” in responding to the needs of individuals and families faced with real-life stressors – from handling unemployment, accessing insurance coverage and finding financial assistance, to dealing with anxiety and grief. Lucy Ramirez, MSW, LCSW and Jeannie Aschkenasy, PhD will focus on the need for social workers to also attend to their own stress and well-being. They will teach effective ways and good self-care practices for social workers to cope with the challenges of their work in these demanding times.

“Poverty and Barriers in Health Care”
Wednesday, August 5th 6pm-7pm

Join Diane Bartlett, LCSW, OSW-C, Bob Louden, MSW, LCSW, and Christi Humphrey, LCSW for an in-depth understanding of how poverty can negatively affect the treatment and health outcomes of a patient with a bleeding disorder. This session will enable you to identify poverty and socio-economic issues that can often dictate a patient's treatment outcomes. From a social work perspective, you will gain strategies on how to manage and guide individuals or families living with such challenges to help achieve the best and most successful medical outcomes. There will be ample time for Q&A.

For more information:

NHF’s 72nd Virtual Bleeding Disorders Conference: Provider Education for Physicians, Pharmacists, Nurses, Nurse Practitioners, and Social Workers is jointly provided by Postgraduate Institute for Medicine and the National Hemophilia Foundation.

The medical, nursing, and social work tracks are supported by independent educational grants from Grifols USA, BioMarin, Sangamo Therapeutics, Takeda, Novo Nordisk, and uniQure.